Feed/Investors/DawnBiopharma

DawnBiopharma

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2025-10-16

ROUNDS

joined, none as lead

ROUNDS JOINED · USD

$122.3M

across 1 round

LATEST ROUND

Series A · $122.3M · 2025-10-16

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Company	Round	Amount	Announced	Role
ADCytherix Adcytherix is a biopharmaceutical company focused on the development of novel antibody drug conjugates (ADC) to treat high unmet need diseases such as cancer.	Series A Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it.	$122.3M	2025-10-16	[ PART ]